Allegheny Health Network recognized as first Elekta Center of Distinction

Print Friendly, PDF & Email

Partnership between leaders in precision radiation medicine advances research and physician education and training to provide patients with optimized care and outcomes

Elekta, the leader in precision radiation medicine innovation, has recognized Allegheny Health Network (AHN) as the first Elekta Center of Distinction in the Americas and in fact, the very first in the world. This designation reflects AHN’s commitment to leadership and innovation in the field of precision radiation medicine and its ongoing ability to translate this commitment into improved patient care and outcomes.

“Over the past five years, Elekta and AHN have worked collaboratively not only to bring precision radiation medicine to patients in Pennsylvania, but also to train clinicians from around the country on how to optimize clinical use of Elekta innovations to improve patient care and to conduct clinical research that enables new treatment paradigms,” said Peter Gaccione, Executive Vice President, Region North and Latin America. “We are very pleased to recognize AHN as the first Elekta Center of Distinction.”

AHN Cancer Institute offers patients a full range of Elekta cancer fighting technologies, including Leksell Gamma Knife® Icon radiosurgery system, Brachytherapy Flexitron® afterloader, Elekta Infinity and VersaHD advanced linear accelerators, Monaco® treatment planning system, MOSAIQ® OIS and Elekta Unity MR-Linac system.

AHN is an Elekta Care Learning Partner and Clinical Observation site that collaborates with Elekta to offer clinical, physics and technical learning experiences to members of the radiation oncology community, and a reference site partner that provides demonstrations on the safe and effective use of Elekta technologies. AHN has also joined the Elekta MR-linac Consortium, a global collaboration among leading cancer care and centers and industry partners that is developing the clinical regimens and workflows to optimize the use of Elekta Unity in specific tumor anatomies.

“We are honored by this designation that recognizes that our cancer institute and radiation oncology teams are operating at the highest levels of leadership, expertise, collaboration and innovation.”

“This important collaboration with leading industry, clinical and academic experts from around the world further advances our personalized medicine, immunotherapy, research, and education programs as we continue to integrate clinical, genomic, and payer functions and data to improve and transform healthcare outcomes,” said David Parda, MD, Chair, AHN Cancer Institute. “We are honored by this designation that recognizes that our cancer institute and radiation oncology teams are operating at the highest levels of leadership, expertise, collaboration and innovation. We look forward to hosting educating representatives of other cancer care centers throughout the United States about Elekta’s outstanding solutions for cancer patients.”

Next Previous Home